P33981 (TTK_HUMAN) Homo sapiens (Human)

Dual specificity protein kinase TTK UniProtKBInterProSTRINGInteractive Modelling

857 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

78 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepi…
3h9f
homo-4-mer519-794
8×MG; 4×92M;
Assess
HUMAN MPS1 IN COMPLEX WITH NMS-P715
2x9e
homo-2-mer515-795
2×SVE;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5eh0
homo-2-mer516-794
2×5NW; 2×DMS;
Assess
Crystal structure of TTK kinase domain
3dbq
monomer515-796
Assess
Crystal structure of TTK kinase domain in complex with compound 7
7cil
monomer515-795
1×FZR;
Assess
Crystal structure of TTK kinase domain in complex with compound 9
7chn
monomer515-795
1×FZL;
Assess
Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine
3hmo
monomer514-794
1×7PE; 1×STU; 3×IPA; 4×GOL;
Assess
Human Mps1 kinase domain with ordered activation loop
6gvj
monomer515-795
6×GOL; 2×CL;
Assess
Crystal structure of TTK kinase domain in complex with compound 28
7cja
monomer515-795
1×G0U;
Assess
Human TTK in complex with a Dyrk1B inhibitor
4d2s
monomer513-793
1×DYK;
Assess
Crystal Structure of TTK kinase domain with an inhibitor: 400740
4jt3
monomer515-794
4×PO4; 1×1PH; 10×EDO;
Assess
Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor
4zeg
monomer516-795
1×GOL; 1×PEG; 6×EDO; 1×052;
Assess
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridi…
3vqu
monomer516-795
8×IOD; 1×O22;
Assess
Crystal structure of TTK kinase domain in complex with compound 30
7cht
monomer515-794
1×FZO; 2×MG;
Assess
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16
6tn9
monomer515-794
1×NN5;
Assess
Crystal structure of the human TTK in complex with an inhibitor
6n6o
monomer515-794
1×KE7; 1×1PE; 1×EDO;
Assess
Crystal structure of Human MPS1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1H-pyrazol…
3w1f
monomer516-795
1×1O5;
Assess
Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor
2zmd
monomer516-795
1×537; 1×7PE;
Assess
Crystal structure of TTK kinase domain in complex with compound 19
7clh
monomer516-795
1×G5C;
Assess
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1…
3wyx
monomer516-795
1×IOD; 1×O38;
Assess
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH (E)-3-(4-((6-(((3s,5s,7s)-adamanta…
3wyy
monomer516-795
1×O17;
Assess
Crystal structure of TTK kinase domain with an inhibitor: 401348
4js8
monomer515-793
1×1PF; 2×SO4; 2×PEG; 2×GOL;
Assess
Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4
3hmp
monomer516-794
1×CX4; 1×7PE; 1×PEG; 3×GOL; 3×IPA;
Assess
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-yl…
3wzk
monomer516-794
1×CL; 1×O23;
Assess
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46
6tnc
monomer516-794
1×O23; 1×CL;
Assess
Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]…
4o6l
monomer515-793
1×2QK; 1×GOL;
Assess
Crystal structure of TTK kinase domain in complex with compound 8
7chm
monomer516-794
1×FZF;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5ei2
monomer516-794
1×5O7;
Assess
Crystal structure of human Mps1 catalytic domain in complex with ATP
3hmn
monomer516-794
1×ATP; 1×7PE;
Assess
Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715
5ntt
monomer519-797
1×SVE; 2×EDO;
Assess
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrah…
3wzj
monomer516-794
1×O43;
Assess
TTK in Complex with Inhibitor
6b4w
monomer515-793
1×CQ7; 1×CAC;
Assess
Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form
2zmc
monomer516-794
1×7PE;
Assess
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79
6tnd
monomer516-793
1×8RH;
Assess
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41
6tnb
monomer517-794
1×8QW; 1×CL;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5ehl
monomer519-796
1×0SQ;
Assess
Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5
5o91
monomer519-796
1×C5N; 1×EDO;
Assess
Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor
7lqd
monomer519-795
1×YB4; 5×GOL; 1×TOE;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap1
monomer519-795
1×O38; 4×GOL; 3×MG;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap0
monomer519-795
1×AU5; 2×P4C; 3×DMS; 13×EDO;
Assess
Crystal structure of human Mps1 (TTK) in complex with Cpd-5
5mrb
monomer519-795
1×C5N; 12×EDO; 1×CL;
Assess
Crystal structure of human Mps1 (TTK) in complex with Reversine
5ljj
monomer519-795
1×AD5; 1×EDO;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5ei6
monomer519-794
1×5OQ; 2×DMS;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap6
monomer519-794
1×PWU; 10×EDO; 1×DMS;
Assess
TTK kinase domain in complex with TC-Mps1-12
5n93
monomer519-794
1×8QE;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5eho
monomer519-794
1×5O1; 1×DMS;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5ehy
monomer519-794
7×7PE; 1×5O4; 5×EDO; 1×DMS;
Assess
TTK kinase domain in complex with NTRC 0066-0
5n87
monomer519-794
1×N66; 1×PGF; 1×NA;
Assess
TTK kinase domain in complex with Mps-BAY2b
5n84
monomer519-794
1×8Q5; 5×NA; 1×PG0;
Assess
Crystal structure of human dual specificity protein kinase (TTK)
3cek
monomer519-794
2×7PE;
Assess
TTK kinase domain in complex with BAY 1161909
5n9s
monomer519-794
1×8QW;
Assess
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4c4f
monomer519-794
3×7PE; 1×7CE; 3×EDO;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap7
monomer519-794
1×SVE; 5×EDO; 1×DMS;
Assess
Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enab…
6h3k
monomer519-794
1×FMW; 1×7PE;
Assess
MPS1 kinase with 3-aminopyridin-2-one inhibitors
4cva
monomer519-794
1×WBI; 2×DMS; 2×EDO;
Assess
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4c4j
monomer519-794
1×X21;
Assess
MPS1 kinase with 3-aminopyridin-2-one inhibitors
4cv9
monomer519-794
1×W2K; 5×EDO; 1×DMS;
Assess
TTK kinase domain in complex with MPI-0479605
5n7v
monomer519-794
1×8PT; 2×7PE;
Assess
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4c4e
monomer519-794
1×4T9; 1×1PE; 4×7PE;
Assess
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4c4g
monomer519-794
1×7RO; 2×7PE; 2×EDO;
Assess
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4c4i
monomer519-794
1×X20; 1×7PE;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap3
monomer519-794
4×7PE; 1×AU5; 1×DMS; 3×EDO;
Assess
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor
4bi1
monomer519-794
4×7PE; 1×ZO6; 4×EDO;
Assess
Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin l…
3gfw
monomer519-794
1×S22; 2×7PE;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap5
monomer519-794
1×7RO; 1×1KA; 1×PGE; 2×EDO;
Assess
TTK kinase domain in complex with BAY 1217389
5nad
monomer519-794
1×8RH;
Assess
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4c4h
monomer519-794
1×7RO; 1×7PE;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap2
monomer519-794
1×PWU;
Assess
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor
4bi0
monomer519-794
2×7PE; 1×Z0W; 1×EDO;
Assess
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor
4bhz
monomer519-794
2×7PE; 1×Z0B; 1×EDO;
Assess
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.
5ap4
monomer519-794
1×O38; 2×7PE; 2×EDO;
Assess
TTK kinase domain in complex with a PEG-linked pyrimido-indolizine
5na0
monomer519-794
1×8QZ;
Assess
MPS1 kinase with 3-aminopyridin-2-one inhibitors
4cv8
monomer519-794
1×3D7; 4×EDO;
Assess
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor
4bi2
monomer519-794
2×EDO; 1×7PE; 1×ZO8;
Assess
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …
5ei8
monomer519-753
1×5OE; 3×DMS;
Assess
Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin…
4h7y
monomer59-199
Assess
Crystal structure of human Mps1 TPR domain
4b94
monomer62-199
1×PG4; 2×GOL;
Assess
Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin…
4h7x
monomer59-196
1×PB;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6gvj.1.Amonomer0.76515-795
100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26gvj.1.Amonomer0.76514-794
100.00
Assess